DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Smith M, Parker C, Saad F. et al.
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): A randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol 2019;
20: 408-419
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.